Centene Q3 2024 Earnings Report
Key Takeaways
Centene Corporation announced its third quarter 2024 financial results, featuring adjusted diluted EPS of $1.62 and premium and service revenues of $36.9 billion. The company reaffirmed its 2024 adjusted diluted EPS guidance floor of greater than $6.80. Membership increased in Marketplace and Medicare Prescription Drug Plans. Centene executed capital deployment with $1.2 billion of share repurchases during the quarter.
Adjusted diluted EPS was $1.62 in the third quarter of 2024.
Premium and service revenues reached $36.9 billion in the third quarter of 2024.
Marketplace membership increased by 22% and Medicare Prescription Drug Plans membership increased by 49% compared to the third quarter of 2023.
The company repurchased $1.2 billion of shares during the third quarter of 2024, bringing full-year repurchases to $2.4 billion through October 2024.
Centene
Centene
Centene Revenue by Segment
Forward Guidance
Centene is updating its 2024 GAAP diluted EPS guidance floor to greater than $5.92 and reaffirming its 2024 adjusted diluted EPS guidance floor of greater than $6.80.
Revenue & Expenses
Visualization of income flow from segment revenue to net income